VINCERX PHARMA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5908 USD | +2.95% |
|
-1.68% | -49.92% |
| 05-14 | Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-26 | Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VINCERX PHARMA, INC. | Bio Therapeutic Drugs | +2.95% | -1.68% | -49.92% | -54.55% | - | 16.95M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VINC Stock
- Charts Vincerx Pharma, Inc.
- Comparison Chart
